Real World Evidence on the effectiveness of ustekinumab in Crohn's Disease: Induction phase results from the prospective, observational RUN-CD Study (2021) Bokemeyer B, Plachta-Danielzik S, Di Giuseppe R, Mohl W, Teich N, Hoffstadt M, Schweitzer A, et al. Conference contribution The JAK1/3 Inhibitor to Tofacitinib Suppresses T Cell Homing and Activation in Chronic Intestinal Inflammation (2021) Gerlach K, Lechner K, Popp V, Offensperger L, Zundler S, Wiendl M, Becker E, et al. Journal article The TLR9 agonist cobitolimod induces IL10 producing wound healing macrophages and regulatory T cells in ulcerative colitis (2020) Schmitt H, Ulmschneider J, Billmeier U, Scarozza P, Sonnewald S, Reid S, Atreya I, et al. Journal article, Original article The first real-life multicentre prospective validation study of the electronic chromoendoscopy score (Paddington International Virtual ChromoendoScopy ScOre) and its outcome in ulcerative colitis (2020) Iacucci M, Smith SC, Bazarova A, Shivaji UN, Bhandari P, Cannatelli R, Daperno M, et al. Conference contribution Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics (2020) Bokemeyer B, Plachta-Danielzik S, Sobotzki C, Mohl W, Hoffstadt M, Krause T, Atreya R, et al. Conference contribution An IFN-STAT1-MLKL axis drives programmed necrosis of Paneth cells in Crohn's ileitis (2020) Hartmann L, Siegmund B, Weidinger C, Becker C, Neurath M, Günther C Conference contribution Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells (2020) Becker E, Wiendl M, Schulz-Kuhnt A, Atreya I, Atreya R, Neurath M, Zundler S Conference contribution Addiction in IBD patients: more than just smoke? (2019) Hirschmann S, Koehnen J, Schuster B, Atreya R, Krauss N, Mudter J, Dauer M, et al. Conference contribution Immune profiling of adipose tissue in murine models of inflammatory bowel disease (IBD) (2019) Letizia M, Sillke YR, Schmidt F, Günther C, Kunkel D, Glauben R, Siegmund B, Weidinger C Conference contribution